Determination of lead in human saliva by combined cloud point extraction-capillary zone electrophoresis with indirect UV detection

A micelle-mediated phase separation without added chelating agents to preconcentrate trace levels of lead in human saliva as a prior step to its determination by capillary electrophoresis has been developed. The enrichment step is based on the cloud point extraction of lead with the non-ionic surfactant PONPE 7.5 in the absence of chelating agent. The surfactant-rich phase was diluted with acetonitrile and the resultant solution was injected directly into the CE instrument. Factors affecting the combined methodology such as surfactant-rich phase diluting agent, buffer pH and concentration, applied voltage, sample preparation and presence of additives were studied in detail. A BGE of 20 mM imidazole containing 30% acetonitrile, pH 6.20 was found to be optimal for the separation of lead from other saliva constituents. Indirect detection was performed at 205 nm. The detection limit value of lead for the preconcentration of 8 ml of saliva was 11.4 microg l(-1). The calibration graph using the preconcentration system was linear with a correlation coefficient of 0.997 at levels near the detection limits up to at least 400 microg l(-1). The reproducibility (R.S.D.) on the basis of migration time and peak area were better than 0.68 and 3.6%, respectively. The method was successfully applied to the determination of lead in human saliva.     

Chewing Gum as a Drug Delivery System for Nystatin Influence of Solubilising Agents Upon the Release of Water Insoluble Drugs

Abstract

Nystatin is an antifungal drug with a poor solubility in water and saliva. Consequently, only a small amount of the drug was released from nystatin chewing gum during testing on a mastication device. The addition of solubilising agents to chewing gum increased the release of nystatin by a factor of 50–70, whereas the agents only increased the solubility of nystatin by a factor of 3–7. The solubilising agents were Cremophor® RH 40, Tween® 60 (non-ionic surfactants) and Panodan® AB 90 (an-ionic surfactant). There was no linear relationship between the amount of nystatin in chewing gum and the release. A method to estimate the content of nystatin in chewing gum was developed.     

Solventless synthesis of a Schiff base that forms highly fluorescent organic nanoparticles exhibiting aggregation-induced emission in aqueous media

A highly fluorescent solid state Schiff base compound (DBD) was synthesised using a green, solventless and fast approach in 30 sec. DBD shows almost no emission in THF solution, while it emits strong fluorescence in both dispersed nano-aggregates in the solution and as a powder, through a phenomenon known as aggregation-induced emission. Organic nanoparticles of DBD were prepared in aqueous solution using the nanoreprecipitation method with and without stabilizers. The nanoparticles exhibited strong, blue emission when the non-ionic surfactant, like triton X-100, was used as a stabilizer, and strong green emission when no surfactant or the cationic surfactant, like CTAB as a stabilizer was used. Using atomic force microscopy and dynamic light scattering, the sizes of the nanoparticles were found to be around 75 nm when prepared without surfactant, 50 nm when prepared using triton X-100, and 30 40 nm when prepared using CTAB. DBD nanoparticles show an emission maximum at 527 nm (pure green) in the cases of CTAB and no surfactant, while 400 nm emission is observed when triton X-100 is used. Finally, for practical applications, the new type of highly fluorescent organic nanoparticles (DBD) were chosen for on/off fluorescence switching nano sensor for detecting organic vapour.     

Salivary bisphenol-A levels detected by ELISA after restoration with composite resin

Bisphenol-A diglycidylether methacrylate (Bis-GMA), which is synthesized from bisphenol-A (BPA), a compound with exogenous endocrine disrupter action, is widely used as a dental material. During clinical filling with sealants and composite resins, the compounds are solidified by polymerization and then used. However, it has been noted that unpolymerized monomers may become dissolved in saliva. In this study using a competitive ELISA system, we investigated the changes in the BPA concentration in saliva after restoration with composite resins. Commercial composite resins from nine companies were tested. Mixed saliva was collected from 21 subjects. Based on the dynamics of salivary BPA detected by this ELISA system, we concluded that several tens to 100 ng/ml of BPA were contained in saliva after filling teeth with composite resin but that sufficient gargling can remove it from the oral cavity. Our data suggest that sufficient gargling after treatment is important for risk management.     

Effect of a Surfactant on Absorption of AM Antibiotic from Non-Aqueous Parenteral Suspensions

Abstract

Attempts to modify the absorption of a monocyclic beta-lactam antibiotic from an oily suspension formulation were made by incorporation of the non-ionic surfactant sorbitan trioleate. Time to serum peak concentration was increased with increased level of surfactant and there anpeared to be more efficient clearance of the antibiotic from the depot with increase in level of surfactant in the formulation. The second effect may be explained in terms of the physical characteristics of the formulations whereas the alteration in time to serum peak concentrations may be due to an effect of the surfactant on transport of drug throuah tissue.     

Interaction between surfactants and gelatin in aqueous solutions

Abstract

The interaction between certain pairs of synthetic polymers and surfactants in aqueous solution has been studied widely. These systems are of inherent scientific interest and useful properties are imparted by both the polymer (rheological control, stability enhancement) and surfactant (lowering of surface tension, wetting). Here, rather than review the extensive field of synthetic polymer/surfactant systems a selective 'case study' is presented of one type of system, that of gelatin, the anionic surfactant sodium dodecylsulphate (SDS) and, ultimately, the same system in the presence of a competing (for the SDS) non-ionic surfactant. Results from a range of techniques are discussed, and their complementarity and distinctions highlighted. Extensive comparisons with other polymer/surfactant systems are made.     

Miconazole chewing gum as a drug delivery system test of release promoting additives

The release of the antifungal drug miconazole from chewing gum formulations was evaluated in vitro and in vivo. It was proven that the addition of the anionic surfactant Panodan® 165 and polyethyleneglycol 6000 increased the release of miconazole. The anionic surfactant made the chewing gum tacky. The addition of polyethyleneglycol 6000 reduced the tacky properties of the chewing gum. 4 healthy volunteers obtained therapeutically active concentrations of miconazole in saliva when they chewed gum. The salivary concentrations of miconazole were estimated, both by a reverse phase HPLC method and a plate microbioassay.     

Quantitative analysis of multiple exocyclic DNA adducts in human salivary DNA by stable isotope dilution nanoflow liquid chromatography-nanospray ionization tandem mass spectrometry

Exocyclic DNA adducts, including 1,N(2)-propano-2'-deoxyguanosine derived from acrolein (AdG) and crotonaldehyde (CdG) and the three lipid peroxidation-related etheno adducts 1,N(6)-etheno-2'-deoxyadenosine (εdAdo), 3,N(4)-etheno-2'-deoxycytidine (εdCyt), and 1,N(2)-etheno-2'-deoxyguanosine (1,N(2)-εdGuo), play an important role in cancer formation and they are associated with oxidative-stress-induced DNA damage. Saliva is an easily accessible and available biological fluid and a potential target of noninvasive biomarkers. In this study, a highly sensitive and specific assay based on isotope dilution nanoflow LC-nanospray ionization tandem mass spectrometry (nanoLC-NSI/MS/MS) is developed for simultaneous detection and quantification of these five adducts in human salivary DNA. The levels of AdG, CdG, εdAdo, εdCyd, and 1,N(2)-εdGuo, measured in 27 human salivary DNA samples from healthy volunteers, were determined as 104 ± 50, 7.6 ± 12, 99 ± 50, 72 ± 49, 391 ± 198 (mean ± SD) in 10(8) normal nucleotides, respectively, starting with 25 μg of DNA isolated from an average of 3 mL of saliva. Statistically significant correlations were found between levels of εdAdo and εdCyd (γ = 0.8007, p < 0.0001), between levels of εdAdo and 1,N(2)-εdGuo (γ = 0.6778, p = 0.0001), between levels of εdCyd and 1,N(2)-εdGuo (γ = 0.5643, p = 0.0022), between levels of AdG and 1,N(2)-εdGuo (γ = 0.5756, p = 0.0017), and between levels of AdG and εdAdo (γ = 0.3969, p = 0.0404). Only 5 μg of DNA sample was analyzed for simultaneous quantification of these adducts. The easy accessibility and availability of saliva and the requirement for the small amount of DNA samples make this nanoLC-NSI/MS/MS assay clinically feasible in assessing the possibility of measuring 1,N(2)-propano-2'-deoxyguanosine and etheno adducts levels in human salivary DNA as noninvasive biomarkers for DNA damage resulting from oxidative stress and for evaluating their roles in cancer formation and prevention.     

Development of a monoclonal antibody against ochratoxin A and its application in enzyme-linked immunosorbent assay and gold nanoparticle immunochromatographic strip

A monoclonal antibody (mAb) specific to ochratoxin A (OTA) was produced from a stable hybridoma cell line, 9C9H9, generated by the fusion of P3/NS1/1-AG4-1 myeloma cells with spleen cells isolated from a BALB/c mouse immunized with OTA-keyhole limpet hemocyanin. The 9C9H9 mAb belongs to the immunoglobulin G1 (kappa chain) isotype. A competitive direct enzyme-linked immunosorbent assay (cdELISA) and a competitive indirect ELISA were established for antibody characterization. The concentrations causing 50% inhibition of binding of OTA-horseradish peroxidase to the antibody by OTA, OTB, and OTC were found to be 0.32, 0.17, and 0.28 ng/mL, respectively, in the cdELISA. A sensitive and rapid mAb-based gold nanoparticle immunochromatographic strip was also developed using this mAb. This strip has a detection limit of 5 ng/mL for OTA and can be completed in 10 min. Analysis of OTA in coffee samples revealed that data obtained from immunochromatographic strip were in a good agreement with those obtained from cdELISA. The mAb-based cdELISA and immunochromatographic strip assay established in this study were sensitive and accurate for rapid screening of OTA in coffee samples.     

Effect of Surface Modification on Flow Properties and Pressure Filtration of Alumina Slurries

ABSTRACT

The purpose of this research is to evaluate the effectiveness of various dispersants in fine particle processing. The surface of alumina in aqueous solution was modified by using both non-ionic and ionic surfactants. The rheological properties of highly loaded alumina suspensions were studied as a function of surfactant concentration. Pressure filtration experiments were also carried out in order to evaluate the dispersion properties and consolidation behavior. The pressure filtration results could be used to distinguish between well-dispersed and flocculated slurries. The results of rheology measurements and pressure filtration experiments are interpreted using suitable models. To assist the analysis, electrokinetic sonic amplitude (ESA) technique was used for characterization of electrical double layer.     

Enhanced oral bioavailability of lurasidone by self-nanoemulsifying drug delivery system in fasted state

Objective: The purpose of this work was to develop a new formulation to enhance the bioavailability and reduce the food effect of lurasidone using self-nanoemulsifying drug delivery systems (SNEDDSs).

Methods: The formulation of lurasidone-SNEDDS was selected by the solubility and pseudo-ternary phase diagram studies. The prepared lurasidone-SNEDDS formulations were characterized for self-emulsification time, effect of pH and robustness to dilution, droplet size analysis, zeta potential and in vitro drug release. Lurasidone-SNEDDSs were administered to beagle dogs in fed and fasted state and their pharmacokinetics were compared to commercial available tablet as a control.

Results: The result showed lurasidone-SNEDDS was successfully prepared using Capmul MCM, Tween 80 and glycerol as oil phase, surfactant and co-surfactant, respectively. In vitro drug release studies indicated that the lurasidone-SNEDDS showed improved drug release profiles and the release behavior was not affected by the medium pH with total drug release of over 90% within 5?min. Pharmacokinetic study showed that the AUC_(0–∞) and C_max for lurasidone-SNEDDS are similar in the fasted and fed state, indicating essentially there is no food effect on the drug absorption.

Conclusion: It was concluded that enhanced bioavailability and no food effect of lurasidone had been achieved by using SNEDDS.     

Chewing Gum as a Drug Delivery System for Nystatin Influence of Solubilising Agents Upon the Release of Water Insoluble Drugs

Nystatin is an antifungal drug with a poor solubility in water and saliva. Consequently, only a small amount of the drug was released from nystatin chewing gum during testing on a mastication device. The addition of solubilising agents to chewing gum increased the release of nystatin by a factor of 50-70, whereas the agents only increased the solubility of nystatin by a factor of 3-7. The solubilising agents were Cremophor® RH 40, Tween® 60 (non-ionic surfactants) and Panodan® AB 90 (an-ionic surfactant). There was no linear relationship between the amount of nystatin in chewing gum and the release. A method to estimate the content of nystatin in chewing gum was developed.     

Immunochromatographic assay on thread

Lateral-flow immunochromatographic assays are low-cost, simple-to-use, rapid tests for point-of-care screening of infectious diseases, drugs of abuse, and pregnancy. However, lateral flow assays are generally not quantitative, give a yes/no answer, and lack multiplexing. Threads have recently been proposed as a support for transporting and mixing liquids in lateral-flow immunochromatographic assays, but their use for quantitative high-sensitivity immunoassays has yet to be demonstrated. Here, we introduce the immunochromatographic assay on thread (ICAT) in a cartridge format that is suitable for multiplexing. The ICAT is a sandwich assay performed on a cotton thread knotted to a nylon fiber bundle, both of which are precoated with recognition antibodies against one target analyte. Upon sample application, the assay results become visible to the eye within a few minutes and are quantified using a flatbed scanner. Assay conditions were optimized, the binding curves for C-reactive protein (CRP) in buffer and diluted serum were established and a limit of detection of 377 pM was obtained. The possibility of multiplexing was demonstrated using three knotted threads coated with antibodies against CRP, osteopontin, and leptin proteins. The performance of the ICAT was compared with that of the paper-based and conventional assays. The results suggest that thread is a suitable support for making low-cost, sensitive, simple-to-use, and multiplexed diagnostic tests.     

Disposition of 14C-Quinelorane in Dogs Following Oral or Intravenous Dosing and Transdermal Patch Application

Abstract

A transdermal patch was developed to circumvent the emesis associated with the oral and intravenous administration of a dopamine agonist, quinelorane, to dogs.

Approximate steady-state plasma concentrations were achieved following the daily application of a transdermal patch for 7 days. Each dog received between 0.1 and 0.2 mg/kg per day from the transdermal patch.

At steady-state conditions, dogs received either a single oral dose of ¹⁴C-quinelorane at 0.1 mg/kg, a bolus intravenous dose of 0.03 mg/kg or had a transdermal patch containing the radioactive free base, ¹⁴C-quinelorane, applied to their abdomens for 24 hours; the approximate dose was 0.18 mg/kg.

The plasma pharmacokinetics were measured by liquid scintillation counting and ELISA.

The systemic bioavailability of quinelorane, as measured by the ELISA, was 30%, indicative of first-pass metabolism.

The radioactive urinary metabolite profile was similar for all three routes of administration. Principal entities in the urine were quinelorane, the N-despropyl- and the hydroxy-lactam- metabolites, accounting for 29, 25 and 3% of the dose, respectively. The major route of excretion of radioactivity was via. the urine, irrespective of the route by which the drug was administered.     

Surfactant Solutions as Media for Dissolution Testing of A Poorly Water-Soluble Drug

Abstract

The solubility of a poorly water soluble drug. 4-(4-biphenylyl)-butanol (I) was dramatically enhanced in the presence of anionic, cationic and non-ionic surfactants. Since I has no bioavailability problems on oral dosing of capsules, physiological surfactants may be involved in the solubilization of I in vivo. Thus, surfactant solutions were selected as the most relevant media for dissolution testing of capsules of I. The intrinsic dissolution of I was examined in water, sodium dodecyl sulfate (SDS), and polyoxyethylene lauryl ether (POE lauryl ether) solutions, and increases were observed. Capsule dissolution in SDS solutions was not very successful: possible reasons are discussed. POE lauryl ether was selected as the surfactant of choice. The intrinsic dissolution rates were not a linear function of concentration of POE lauryl ether in the medium. Reasons for these observations are discussed. Dissolution of capsules was examined in various concentrations of the surfactant and an optimum concentration selected.     

大菱鲆疾病早期快速检测方法——胶体金免疫层析试纸的研制与建立

使用成分单一的牛血清白蛋白(BSA)为模拟病原,以胶体金标记兔抗血清(即大菱鲆免疫球蛋白多抗)作为检测示踪物,并分别将BSA和葡萄球菌A蛋白印记到硝酸纤维素膜上制成检测线和对照线,通过一系列工艺创制与组装配套,首次成功制备了一套完整的大菱鲆抗体快速检测试纸。采用大菱鲆抗BSA血清作为阳性样本,以健康大菱鲆血清作为阴性样本,用以检验试纸的性能,并与酶联免疫吸附实验(ELISA)法检测结果相比较。结果表明:本试纸检测抗体的特异性与敏感性均很高,与ELISA方法相当,而且使用方便,不需专业技能和额外的试剂与辅助仪器设备,5 min内即可用裸眼获得观察结果,很适合于基层生产操作及户外调研使用。以该实验为基础建立起来的抗体检测试纸,亦可推广应用于其他病害抗体的检测,可为鱼类疾病早期发生提供简易、快捷和操作性强的诊断方法。     

Solubilization of Paracetamol Using Non-Ionic Surfactants and Co-Solubilizers

Abstract

The influence of certain aqueous non-ionic surfactants, cosolvents and cosolvent - surfactant blends on the enhanced solubility of paracetamol were studied. Dielectric constants of these solvent systems with and without paracetamol were determined. In several instances, paracetamol was increased in solubility by 5-7 fold, depending on the system used. Dielectric constants were affected to varying degrees by these systems.

The cosolvents, propylene glycol and glycerin apparently suppress micelle formation.     

In situ investigation of surfactants’ effect onto electrochemical synthesis and properties of polyfurans

Polyfuran (PFu) films were electrochemically deposited onto gold electro-quartz crystal microbalance (EQCM) electrodes using acetonitrile (ACN)/LiClO₄ solvent-electrolyte in presence of dodecylbenzenesulfonic acid (anionic, DBSA) and polyethylene glycol sorbitan monolaurate (non-ionic, Tween 20) surfactants. The effect of surfactants on structural and conductivity properties of the polymer films was investigated using Fourier transform-infrared spectroscopy (FT-IR) and four-probe conductivity measurements. The doping effects of surfactants onto the properties of PFu were correlated with mass gain using in situ EQCM. The conductivity of PFu polymer was measured for PFu with no surfactant and for PFu in presence of two surfactants (Tween 20 and DBSA). Our data indicate that although a fast polymerization, a sharp shift in the frequency and mass changes of the polymer films as well as the highest recorded conductivity of 0.048 S cm^?1 were all obtained for the PFu/Tween 20-2 sample, significantly more PFu films formed with PFu/DBSA than with PFu/Tween 20 samples. We concluded that more PFu films can be obtained when an oxidant and an anionic surfactant (DBSA) are used than when an oxidant is used alone, or when an oxidant is used with a non-ionic surfactant (Tween 20). A part of an anionic surfactant can be incorporated into a PFu structure like an oxidant anion and can act as co-dopant.     

Lab-on-a-disc for fully integrated multiplex immunoassays

This paper presents a cost-effective, rapid, and fully automated lab-on-a-disc for simultaneous detection of multiple protein biomarkers in raw samples such as whole blood or whole saliva. For the diagnosis of cardiovascular disease, here, a novel centrifugal microfluidic layout was designed to conduct the simultaneous detection of high sensitivity C-reactive protein, cardiac troponin I, and N-terminal pro-B type natriuretic peptide based on a bead-based sandwich type enzyme-linked immunosorbent assay (ELISA). Three reaction chambers are initially interconnected for the common processes such as sample injection, incubation, and washing and then isolated on-demand for the independent processes such as substrate incubation and final detection. The assay performances such as the limit of detection and the dynamic range were comparable with those of the conventional ELISA despite the significant reduction of the minimum sample volume (200 μL), the amount of washing buffer (700 μL), and the total process time (20 min).